AFL vs MIST · P/E 14, rev $17.16B vs $160.6M cap
Aflac Incorporated (AFL) versus Milestone Pharmaceuticals Inc (MIST) — a side-by-side from cached financials, not a winner call.
Aflac Incorporated (AFL) is a insurance - life company listed on US.
Milestone Pharmaceuticals Inc (MIST) is a biotechnology company listed on US.
Latest reported AFL revenue for 2025-12-31 was $17.16B. Net income was $3.65B. Revenue was down 9.3% from 2024-12-31 to 2025-12-31. AFL currently screens at market cap $60.18B and trailing P/E 13.5.
MIST does not have a complete income-statement cache yet.
AFL currently screens at market cap $60.18B and trailing P/E 13.5. MIST currently screens at market cap $160.6M.
Not investment advice. Open the AFL and MIST stock pages for the full models.
Not investment advice.